Satya Prakash is a Renowned Professor of McGill University and Founder of Several Bioengineering Companies (MangoGen Pharma, Nanora Pharma and Micropharma, and Proviva Pharma). He holds a Ph.D. in Biomedical Engineering from the Faculty of Medicine and Health Sciences, McGill University, Canada. He has contributed to the advancement and understanding of the human microbiome and probiotic formulations for use in neurological disorders (i.e., Alzheimer's and Parkinson's Diseases), aging, metabolic syndrome, obesity, and cardiovascular diseases. He is a Fellow of the Royal Society of Canada. His work also has advanced medical devices such as the next generation of stents, film dressing, and targeted delivery of drugs, live cells, and therapeutic molecules.